12:00 AM
 | 
Oct 24, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Allob: Additional Phase IIa data

Additional data from 8 patients with symptomatic degenerative lumbar disc disease that required interbody fusion in an open-label, Belgian Phase IIa trial showed that a single implantation of Allob mixed with bioceramic granules into the lumbar interbody fusion site led to successful spinal fusion as determined by dynamic x-rays in...

Read the full 230 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >